# Aerovance

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aerovance

- Industry: Pharmaceuticals
- Headquarters: Berkeley, US
- Total disclosed funding: $130M
- Latest round: Series C (Apr 8, 2009)
- Investors on record: 8

## About

Founded in 2004 and based in Berkeley, US, Aerovance, Inc. operates as a manufacturer and distributor of medical drugs for respiratory diseases.

## Funding rounds

- Series C, Apr 8, 2009, $38M — Alta Partners, Apax Partners, Burrill & Company, NGN Capital, Clarus Ventures, BB Biotech, ProQuest Investments, Lehman Brothers
- Series C, Mar 27, 2007, $32M — Alta Partners, Apax Partners, Burrill & Company, NGN Capital, Clarus Ventures, Lehman Brothers
- Series C, May 8, 2006, $28M — Alta Partners, Apax Partners, Burrill & Company, NGN Capital, Clarus Ventures, Lehman Brothers
- Series B, Aug 23, 2004, $32M — Apax Partners, Burrill & Company, NGN Capital, Lehman Brothers

## Investors

- Apax Partners (https://capitalatlas.ai/funds/apax-partners) — Series B, Series C
- Burrill & Company (https://capitalatlas.ai/funds/burrill-company) — Series B, Series C
- NGN Capital (https://capitalatlas.ai/funds/ngn-capital) — Series B, Series C
- Lehman Brothers (https://capitalatlas.ai/funds/lehman-brothers) — Series B, Series C
- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series C
- Clarus Ventures (https://capitalatlas.ai/funds/clarus-ventures) — Series C
- BB Biotech (https://capitalatlas.ai/funds/bb-biotech) — Series C
- ProQuest Investments (https://capitalatlas.ai/funds/proquest-investments) — Series C